Invasive pneumococcal disease in Indian adults: 11 years' experience

Autor: Ranjith Jayaraman, Rosemol Varghese, Jones Lionel Kumar, Ayyanraj Neeravi, Devika Shanmugasundaram, Ravikar Ralph, Kurien Thomas, Balaji Veeraraghavan
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Journal of Microbiology, Immunology and Infection, Vol 52, Iss 5, Pp 736-742 (2019)
Druh dokumentu: article
ISSN: 1684-1182
DOI: 10.1016/j.jmii.2018.03.004
Popis: Purpose: To investigate the epidemiology of invasive pneumococcal disease (IPD), prevalent serotypes, and pattern of antimicrobial resistance (AMR) in Indian adults. Methods: Prospective laboratory based surveillance of IPD was carried out in >18 years age group between January 2007 and July 2017, from a tertiary care hospital in South India. All Streptococcus pneumoniae culture positives from blood, CSF and sterile body fluids were characterized to identify the serotypes and AMR. Results: A total of 408 IPD cases were characterized in this study. The overall case fatality rate in this study was 17.8% (95% confidence interval (CI): 14.1, 22.4). Pneumonia (39%), meningitis (24.3%), and septicaemia (18.4%) were the most common clinical conditions associated with IPD. Serotypes 1, 3, 5, 19F, 8, 14, 23F, 4, 19A and 6B were the predominant serotypes in this study. Penicillin non-susceptibility was low with 6.4% Conclusion: Serotype data from this study helped in accurate estimation of pneumococcal conjugate vaccine-13 and pneumococcal polysaccharide vaccine-23 protective coverage against serotypes causing IPD in India as 58.7% (95% CI: 53.8, 63.4) and 67.4% (95% CI: 62.7, 71.8) respectively. Penicillin non-susceptibility in meningeal IPD cases is 27.4%. Empirical therapy for meningeal IPD must be cephalosporin in combination with vancomycin since cefotaxime non-susceptibility in meningeal IPD is 9.9% Keywords: Invasive pneumococcal disease, Adults, India, Vaccine coverage, Penicillin resistance
Databáze: Directory of Open Access Journals